| Ma, Ding |
L-MOCA, NCT03534453: Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy |
|
|
| Active, not recruiting | 3 | 229 | RoW | Olaparib 300mg tablets | AstraZeneca | Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy, Platinum Sensitive | 12/24 | 12/24 | | |
BGB-290-302, NCT03519230: Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer |
|
|
| Active, not recruiting | 3 | 224 | RoW | Pamiparib capsule, BGB-290, Placebo capsule | BeiGene | Ovarian Cancer | 06/25 | 06/26 | | |
|
|
NCT04723875: Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline |
|
|
| Active, not recruiting | 3 | 306 | RoW | Paclitaxel or docetaxel + Cisplatin or carboplatin | Huazhong University of Science and Technology, Women's Hospital School Of Medicine Zhejiang University, Qilu Hospital of Shandong University, Obstetrics & Gynecology Hospital of Fudan University, First Affiliated Hospital of Chongqing Medical University, Hunan Cancer Hospital, The Third Xiangya Hospital of Central South University | Uterine Cervical Neoplasms, Cervical Cancer | 01/26 | 01/26 | | |
NCT04733820: Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery |
|
|
| Recruiting | 3 | 340 | RoW | Adjuvant chemotherapy | Huazhong University of Science and Technology, Women's Hospital School Of Medicine Zhejiang University, Qilu Hospital of Shandong University, Obstetrics & Gynecology Hospital of Fudan University, First Affiliated Hospital of Chongqing Medical University, Hunan Cancer Hospital, The Third Xiangya Hospital of Central South University | Uterine Cervical Neoplasms, Cervical Cancer | 02/28 | 02/28 | | |
| Recruiting | 2/3 | 440 | RoW | Camrelizumab, Cisplatin, Nab paclitaxel, Radical surgery, external beam radiation therapy (EBRT) + brachytherapy | Tongji Hospital, Southwest Hospital, China, Women Hospital, School of Medicine, Zhejiang University, Anhui Provincial Cancer Hospital, Sichuan Cancer Hospital and Research Institute, Qilu Hospital of Shandong University, Beijing Friendship Hospital, Tianjin Medical University General Hospital, West China Second University Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Xiangya Hospital of Central South University, Gansu Provincial Maternal and Child Health Care Hospital, Zhejiang Cancer Hospital, Shengjing Hospital, Cancer Hospital of Guangxi Medical University | Cervical Cancer, Locally Advanced Cervical Cancer, Concurrent Chemoradiotherapy, Neoadjuvant Chemoimmunotherapy | 03/31 | 03/31 | | |
NACI, NCT04516616: Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer |
|
|
| Active, not recruiting | 2 | 85 | RoW | Cisplatin+Albumin-bound paclitaxel (1 cycle) and PD-1 monoclonal antibody+Cisplatin+Albumin-bound paclitaxel (2 cycles) | Huazhong University of Science and Technology, Women's Hospital School Of Medicine Zhejiang University, Qilu Hospital of Shandong University, Obstetrics & Gynecology Hospital of Fudan University, First Affiliated Hospital of Chongqing Medical University, Army Medical University, China, Peking University People's Hospital, Tianjin Medical University General Hospital, The Second Affiliated Hospital of Harbin Medical University, Chongqing University Cancer Hospital, The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial) | Uterine Cervical Neoplasm, Uterine Cervical Cancer, Cervical Cancer | 04/23 | 07/28 | | |
NCT04590599: A Phase II Clinical Study to Assess the Efficacy and Safety of IBI310 or Placebo Combined With Sintilimab for Advanced Cervical Cancer Subjects Who Have Failed or Cannot Tolerate First-line or Above Platinum-based Chemotherapy |
|
|
| Completed | 2 | 205 | RoW | IBI310, Placebo, Sintilimab, IBI308 | Innovent Biologics (Suzhou) Co. Ltd. | Advanced Cervical Cancer | 11/23 | 11/23 | | |
| Recruiting | 2 | 40 | RoW | Camrelizumab, Cisplatin, Nab paclitaxel, biopsy | Tongji Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Women Hospital, School of Medicine, Zhejiang University, Third Military Medical University, Beijing Friendship Hospital, Sichuan Cancer Hospital and Research Institute, Tianjin Medical University, West China Second University Hospital, Xiangya Hospital of Central South University, Qilu Hospital of Shandong University, Gansu Cancer Hospital, Zhejiang Cancer Hospital, Shengjing Hospital, Anhui Provincial Cancer Hospital | Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Fertility Preservation | 12/25 | 12/30 | | |
NCT06289751: Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer |
|
|
| Recruiting | 2 | 50 | RoW | Cadonilimab, Cadonilimab Injection, AK104, Paclitaxel-albumin, Injectable paclitaxel (albumin bound), Cisplatin, Cisplatin injection, Extrafascial hysterectomy, Radical hysterectomy, Cone biopsy | Tongji Hospital, The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial), Women Hospital, School of Medicine, Zhejiang University, Southwest Hospital, China, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Sichuan Cancer Hospital and Research Institute, Qilu Hospital of Shandong University, Beijing Friendship Hospital, Tianjin Medical University, West China Second University Hospital, Xiangya Hospital of Central South University, Gansu Provincial Maternal and Child Health Care Hospital, Zhejiang Cancer Hospital, Shengjing Hospital | Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Radical Hysterectomy, Extrafascial Hysterectomy | 03/26 | 01/31 | | |
| Recruiting | 2 | 40 | RoW | Camrelizumab, SHR-1210, Paclitaxel-albumin, Injectable paclitaxel (albumin bound), Cisplatin, Cisplatin injection, radical surgery | Tongji Hospital, Southwest Hospital, China, Women Hospital, School of Medicine, Zhejiang University, Anhui Provincial Cancer Hospital, Sichuan Cancer Hospital and Research Institute, Gansu Provincial Maternal and Child Health Care Hospital, Beijing Friendship Hospital, Tianjin Medical University General Hospital, Xiangya Hospital of Central South University, West China Second University Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Zhejiang Cancer Hospital, Shengjing Hospital, Qilu Hospital of Shandong University, Cancer Hospital of Guangxi Medical University | Cervical Cancer, Locally Advanced Cervical Cancer, PD-L1 Negative, Neoadjuvant Chemoimmunotherapy | 12/25 | 12/30 | | |
NCT05325229: A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer |
|
|
| Recruiting | 2 | 94 | RoW | Docetaxel for injection (Albumin-bound), Bevacizumab | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Platinum-resistant Recurrent Ovarian Cancer | 12/24 | 12/24 | | |
NCT03226470: Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions |
|
|
| Recruiting | 1 | 40 | RoW | T512, TALEN-T512 | Huazhong University of Science and Technology | Human Papillomavirus-Related Malignant Neoplasm | 02/22 | 06/22 | | |
NCT06336707: HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors |
|
|
| Recruiting | 1 | 1048 | RoW | HS-20089, Adebrelimab, Bevacizumab, Cisplatin / carboplatin | Hansoh BioMedical R&D Company | Advanced Solid Tumors | 04/26 | 04/28 | | |
RWS-01, NCT03955185: Clinical Trial of Minimally Invasive Surgery Versus Abdominal Surgery in Patients With Early Stage Cervical Cancer |
|
|
| Recruiting | N/A | 2000 | RoW | minimally invasive surgery, open abdominal surgery | Ding Ma | Uterine Cervical Neoplasm | 05/22 | 05/24 | | |
| Recruiting | N/A | 590 | RoW | Vaginal brachytherapy, External beam radiotherapy, Observation, Chemoradiation therapy | Women's Hospital School Of Medicine Zhejiang University, Tongji Hospital, Qilu Hospital of Shandong University, Obstetrics & Gynecology Hospital of Fudan University, Sun Yat-sen University, Peking University People's Hospital, Shanghai First Maternity and Infant Hospital, Xiangya Hospital of Central South University, Anhui Provincial Cancer Hospital, Ningbo Women & Children's Hospital, Ningbo No. 1 Hospital | Endometrial Cancer Stage I, Endometrial Cancer Stage II | 12/24 | 01/27 | | |
NCT05570331: Clinical Evaluation of HPV Integration Triage for Detection of Cervical Precancer in HPV-positive Women |
|
|
| Recruiting | N/A | 2200 | RoW | HPV integration test | Ding Ma | HPV Infection, Cervical Cancer | 02/23 | 12/25 | | |
NCT04974424: Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV |
|
|
| Recruiting | N/A | 20000 | RoW | | Huazhong University of Science and Technology, Women's Hospital School Of Medicine Zhejiang University, Obstetrics & Gynecology Hospital of Fudan University, Qilu Hospital of Shandong University, Wuhan Central Hospital, Third Military Medical University, Xiangyang Central Hospital, Shenzhen Second People's Hospital | Uterine Cervical Neoplasm, Uterine Cervical Cancer, Cervical Cancer | 12/23 | 12/23 | | |
| Luo, Qiong |
NCT06664554: Predictive Value of Maternal Blood Protein Signatures in Preterm Birth |
|
|
| Completed | N/A | 18000 | RoW | | HBI Solutions Inc., Shenzhen Maternity & Child Healthcare Hospital | Preterm Birth | 06/23 | 06/24 | | |
NCT05186207: Establishment of Special Disease Cohort for RPLand Study of Impact Mechanism of Early Embryo Development |
|
|
| Recruiting | N/A | 1000 | RoW | abnormal pre-pregnancy test results that need clinical intervention | Women's Hospital School Of Medicine Zhejiang University | Recurrent Pregnancy Loss | 12/23 | 12/24 | | |
| Recruiting | N/A | 366 | Canada, RoW | | The George Institute, Peking University Institute of Nephrology | IgA Nephropathy, ESRD, Glomerulonephritis, Kidney Diseases | 07/27 | 07/27 | | |
| Xie, Xing |
NCT04812002: Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy |
|
|
| Recruiting | 2 | 20 | RoW | PD-1 inhibitor， bevacizumab, Camrelizumab for Injection | Women's Hospital School Of Medicine Zhejiang University | Gestational Trophoblastic Neoplasia | 04/24 | 04/26 | | |
NCT04518501: Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer |
|
|
| Recruiting | 1/2 | 50 | RoW | Arsenic trioxide Tablet +Fuzuloparib Capsules | Xing Xie | Efficacy and Safety | 12/24 | 01/25 | | |
NCT03785574: Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule |
|
|
| Recruiting | N/A | 30 | RoW | Follow up, not chemotherapy immediately, chemotherapy, mtx for low risk | Women's Hospital School Of Medicine Zhejiang University | Hydatidiform Mole, Gestational Trophoblastic Neoplasia | 09/24 | 09/25 | | |
| Mao, Yuyan |
EC-01, NCT01820858: The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma |
|
|
| Active, not recruiting | 3 | 300 | RoW | Paclitaxel, Paraplatin (Carboplatin Injection), Pelvic Radiation, Vaginal Brachytherapy 1, Vaginal brachytherapy 2 | Ding Ma, Shandong University, Huazhong University of Science and Technology, Zhejiang University | Endometrial Neoplasms | 12/25 | 12/26 | | |
| Active, not recruiting | N/A | 240 | RoW | TH, TH/BSO, BPLND | Ding Ma, Shandong University, Huazhong University of Science and Technology, Zhejiang University | Endometrial Neoplasms | 12/25 | 12/26 | | |
| Zhu, Yimin |
NCT04744610: Self-controlled Study Between 4-hour and 24-hour Delayed Radiographs in HSG Using OSCM |
|
|
| Recruiting | N/A | 80 | RoW | Add 4-hour delayed radiographs | Women's Hospital School Of Medicine Zhejiang University, Jiangsu Hengrui Pharmaceutical Co., Ltd. | Infertility | 02/21 | 03/21 | | |
NCT04924309: Stress in Couples Undergoing Assisted Reproduction Technology With Donor Sperm and Its Impact on Pregnancy Outcomes |
|
|
| Recruiting | N/A | 200 | RoW | Exposure: donor sperm | Women's Hospital School Of Medicine Zhejiang University | Infertility, Male | 03/22 | 04/22 | | |
NCT05055245: Stress in Couples Undergoing Assisted Reproduction Technology With Different Cycles and Its Impact on Pregnancy Outcomes |
|
|
| Not yet recruiting | N/A | 200 | RoW | cycles | Women's Hospital School Of Medicine Zhejiang University | Infertility | 03/22 | 04/22 | | |
| Chen, Xinzhong |
NCT04548973: A Multicenter Study of the Efficacy and Safety of Esketamine for Analgesia During Cesarean Section |
|
|
| Completed | 4 | 600 | RoW | Esketamine, Normal saline | Women's Hospital School Of Medicine Zhejiang University | Fetal or Neonatal Effect of Damage to Placenta From Caesarean Section | 09/22 | 09/24 | | |
NCT05826327: Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression in Parturients |
|
|
| Recruiting | 4 | 364 | RoW | Esketamine, E, Sufentanil, C | Women's Hospital School Of Medicine Zhejiang University, Peking University First Hospital, Obstetrics & Gynecology Hospital of Fudan University, Beijing Obstetrics and Gynecology Hospital | Postpartum Depression | 06/25 | 12/25 | | |
NCT05594771: Comparative Study of the Loading Dose Administrated Via Epidural Needle or Epidural Catheter for Labor Analgesia |
|
|
| Completed | N/A | 276 | RoW | epidural needle, epidural catheter | Women's Hospital School Of Medicine Zhejiang University | Labor Pain | 08/23 | 08/23 | | |
| Lyv, Weiguo |
NCT05826327: Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression in Parturients |
|
|
| Recruiting | 4 | 364 | RoW | Esketamine, E, Sufentanil, C | Women's Hospital School Of Medicine Zhejiang University, Peking University First Hospital, Obstetrics & Gynecology Hospital of Fudan University, Beijing Obstetrics and Gynecology Hospital | Postpartum Depression | 06/25 | 12/25 | | |
| Jiang, Xiuxiu |
NCT06546397: Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion |
|
|
| Recruiting | 1 | 200 | RoW | 17β-estradiol/dydrogesterone tablets | Women's Hospital School Of Medicine Zhejiang University | Pregnancy Complications | 09/25 | 12/25 | | |
CECS, NCT06485180: Comparative Effectiveness of Uterine Repair Surgery on Preventing Recurrence of Cesarean Sar Pregnancy |
|
|
| Completed | N/A | 606 | RoW | Active comparator | Women's Hospital School Of Medicine Zhejiang University, Peking University | Pregnancy Complications | 12/22 | 06/24 | | |
